Pathogenesis of osteoporosis and challenges for drug delivery.
about
Interaction between immobilized polyelectrolyte complex nanoparticles and human mesenchymal stromal cells.Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancersDifferences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous boneThe mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers.Statins: new drugs for treating osteoporosis?Risedronate-loaded Eudragit S100 microparticles formulated into tablets.Advanced glycation end products and bone loss during aging.
P2860
Q33610495-843FD988-E08D-489F-A4E4-D01602EB3D4CQ35071128-517E01BD-FF9C-4274-AF6C-C8DAF88908C9Q35997620-F4895701-AF0E-4BBD-89E1-B36D1B7AB614Q39564377-4089321A-9BEB-4549-9530-261733A8B04BQ43652660-02E008EA-37D9-4C49-A574-7C6587A0FA43Q46368292-043E796B-2DE2-42BE-B41D-89400504EB2AQ46613220-F316848F-CDF5-4A98-827F-4E3BC16B43A4
P2860
Pathogenesis of osteoporosis and challenges for drug delivery.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pathogenesis of osteoporosis and challenges for drug delivery.
@ast
Pathogenesis of osteoporosis and challenges for drug delivery.
@en
Pathogenesis of osteoporosis and challenges for drug delivery.
@nl
type
label
Pathogenesis of osteoporosis and challenges for drug delivery.
@ast
Pathogenesis of osteoporosis and challenges for drug delivery.
@en
Pathogenesis of osteoporosis and challenges for drug delivery.
@nl
prefLabel
Pathogenesis of osteoporosis and challenges for drug delivery.
@ast
Pathogenesis of osteoporosis and challenges for drug delivery.
@en
Pathogenesis of osteoporosis and challenges for drug delivery.
@nl
P1476
Pathogenesis of osteoporosis and challenges for drug delivery.
@en
P2093
P304
P356
10.1016/S0169-409X(00)00060-0
P407
P577
2000-08-01T00:00:00Z